Search results for "Cirrhosis"


 
Results 51 - 60 of about 123 for "Cirrhosis".
Sort by: Relevance | Newest | Oldest

C. diff-related bloodstream infection seen less often with FMT vs. antibiotics

While fecal microbiota transplantation (FMT) was associated with fewer bloodstream infections than antibiotics in one study, a brief report described two cases of drug-resistant bacteremia transmitted by FMT.
https://gastroenterology.acponline.org/archives/2019/11/22/9.htm
22 Nov 2019

Spotlight on autoimmune hepatitis

One study compared the hospitalization rate for autoimmune hepatitis among black, Latino, and Asian/Pacific Islander patients versus a reference rate among white patients, while another study retrospectively analyzed budesonide as a second-line agent in patients with autoimmune hepatitis initially treated with prednisolone.
https://gastroenterology.acponline.org/archives/2018/02/23/5.htm
23 Feb 2018

Urinary biomarker may help predict cirrhosis outcomes, study finds

Levels of urine liver fatty acid-binding protein could be used together with Model for End-stage Liver Disease scoring to improve predictions of liver failure or death, according to an analysis of patients hospitalized for decompensated cirrhosis.
https://gastroenterology.acponline.org/archives/2021/09/24/3.htm
24 Sep 2021

New HCV drug combo approved

The fixed-dose tablet combines the previously approved drugs sofosbuvir and velpatasvir with a new drug, voxilaprevir.
https://gastroenterology.acponline.org/archives/2017/07/28/10.htm
28 Jul 2017

Daily aspirin may reduce risk of hepatitis-related liver cancer

A Taiwanese nationwide cohort study of more than 10,000 patients with chronic hepatitis B showed a statistically significant 29% risk reduction for hepatocellular carcinoma in patients who received daily aspirin compared with matched controls.
https://gastroenterology.acponline.org/archives/2019/03/22/1.htm
22 Mar 2019

Score predicts hepatic decompensation among patients with NAFLD

Age, presence of diabetes, and platelet count were significant predictors of hepatic events up to 12 years from the time of nonalcoholic fatty liver disease (NAFLD) diagnosis, a retrospective study found.
https://gastroenterology.acponline.org/archives/2020/03/27/1.htm
27 Mar 2020

HCV treatment was successful among patients who used injection drugs

The open-label, single-arm, industry-funded phase 4 trial included patients who had used injection drugs within six months and had chronic hepatitis C virus (HCV), recruited at 19 sites in seven countries.
https://gastroenterology.acponline.org/archives/2018/01/26/2.htm
26 Jan 2018

Beta-blocker monotherapy may be preferred for primary prophylaxis of esophageal variceal bleeding

Guidelines currently recommend nonselective beta-blockers or variceal band ligation for primary prevention of variceal bleeding based on similar efficacy, but survival benefit may be better with the former treatment.
https://gastroenterology.acponline.org/archives/2018/08/24/2.htm
24 Aug 2018

Spotlight on hepatitis B vaccination

The Advisory Committee on Immunization Practices released new recommendations, a CDC-funded study examined vaccination rates among patients who have HIV infection, and the FDA approved a new vaccine.
https://gastroenterology.acponline.org/archives/2018/01/26/5.htm
26 Jan 2018

ACP, CDC issue best practice advice on HBV

Clinicians should screen for hepatitis B virus (HBV) in patients at high risk, such as those born in countries where the HBV prevalence is 2% or higher, men who have sex with men, patients who require immunosuppressive therapy, or patients with end-stage renal disease.
https://gastroenterology.acponline.org/archives/2017/11/28/7.htm
28 Nov 2017

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next